4 Pharmaceutical Stocks With Big Catalysts Pending in 2016
This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny. These four companies with promising candidates all have dates with the agency this year.
This is going to be a big year in biotech, with a host of drugs set to undergo FDA scrutiny. These four companies with promising candidates all have dates with the agency this year.
While analysts expect no real gains in commodity prices this year, many expect 2016 to be a bottom, so we could be at the very start of a global, long-term agriculture boom.
We’re less than a week into the new year, and already the S&P 500 is down over 6%. When trying to work out what exactly is going on, it’s helpful to think quantitatively.
Looking outside the United States can sometimes reveal other companies that offer the same stability, with the added benefit of global diversification if a U.S.-specific problem develops.
Why the time is right for adventurous investors to buy Tesla shares before Wall Street realizes that it overacted to this week’s news.
Here are four stocks that will help you sleep easy regardless of how the broader indexes perform for the rest of this year.
Many on Wall Street are scratching their heads over the latest move by activist investor Carl Icahn.
These three stocks are down 70% for 2015, but are still sound, if struggling companies that have the potential to rebound strongly when conditions change and sentiment reverses.
Here are four Macau stocks that would skyrocket in the event China loosens capital controls on the the Macau gaming scene.
Whole Foods shares have been dropping over much the past year, but recently look like they may have found a bottom during the holiday shopping period.
After piling on Apple in the previous period, short sellers appeared to change their minds in the heart of the holiday shopping season.
General Electric saw its short interest drop sharply again between the November 30 and December 15 settlement dates.
Hyatt Hotels announced Thursday that it recently discovered malicious software designed to steal credit card data on computers that operate the payment processing systems for Hyatt-managed locations.
Here are four stocks that, while expensive at current levels, have fundamentals good enough to continue and even exceed their success in 2015 through next year.
Biotech gets a lot of sustained attention, but some stocks still fall through the cracks, either due to recent failures or general lack of interest.
Here are four stocks that can keep moving higher as the average American tries to get an extra mile out of every dollar.
Credit card companies could be some of the best performing large cap stocks come 2016. Visa Inc. (NYSE: V), American Express Co. (NYSE: AXP), MasterCard Inc. (NYSE: MA) and Discover Financial Services (NYSE: DFS)…
We are approaching the absolute break-even point for oil production, if we haven’t done so already. Then a contraction in supply should translate to a reversal in price.
Yahoo has taken quite a beating in 2015, and the bears are piling up. The September bottom seems to have held for nearly three months now, while sentiment for the stock has yet to…
Biotech looks set to close out 2015 as its worst performing year since 2008. But can we expect a better 2016 for this exciting sector?